| NCT Number | NCT07520747 |
| Lead Sponsor | Janssen Korea, Ltd., Korea |
| Conditions | Inflammatory Bowel Diseases |
| Enrollment | 8,000 participants |
| Start Date | 2026-04-07 |
| Primary Completion | 2026-07-31 (estimated) |
| Study Completion | 2026-07-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-06 |